Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurensin-1 (NRSN1) is a small, membrane-associated protein encoded by the NRSN1 gene on human chromosome 6[1][3][6]. It is predominantly expressed in neural tissues, where it localizes to transport vesicles, growth cones, neuron projections, and neuronal cell bodies[2][3][6]. Neurensin-1 is predicted to play a key role in nervous system development, neural organelle transport, nerve signal transduction, neurite extension, and memory consolidation[1][6]. Mutations or dysregulation of NRSN1 are associated with several neurodevelopmental disorders, including dyslexia and conditions marked by eye movement abnormalities and ataxia[1]. Currently, there are no known drugs that directly target Neurensin-1, and it is not classified as a conventional therapeutic target such as a receptor or enzyme[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurensin-1 (NRSN1).